Flamma USA is a FDA Registered Site that is operated under cGMP. Formerly Teva’s Chemical Synthesis Center, Flamma USA is located in Malvern, PA outside of Philadelphia. Flamma acquired this site in 2019. The 40,000 sq. ft. facility is in close proximity to Boston/Cambridge (1.5 h flight) as well as the greater New York/New Jersey area (1.5 h drive).
Affectionately dubbed “Flamma-delphia”, this extremely well built lab and manufacturing site possesses a cGMP Pilot Plant, 5 standard cGMP kilo lab suites, 1 cGMP HPAPI kilo lab suite (classified to handle potent compounds with an OEL > 0.1μg/m3), 22 fume hoods, an analytical development lab as well as a QC lab, and additional space for future expansion for any necessary analytical, chemistry, and/or warehouse needs. The site previously handled controlled drug substances (Schedule II to IV) and Flamma is moving forward to reactivating the necessary licenses.
This site is dedicated to the development and production of APIs ranging from pre-clinical/clinical phases (I to III) and up to small scale commercial phase manufacturing. Flamma plans to grow the site to 60 employees by 2023 and looks forward to attracting talented personnel that reside in the Philly area.
If you would like to have a site visit to see the value that Flamma can bring to your company , please contact Kenneth Drew, Ph.D., VP Flamma USA via the contact page by using the drop down menu for “Direct contact to North America Representative”
Do you want to learn more about the Malvern site?
Download the Flamma Malvern Brochure